TOP STORIES

• BUSINESS AbbVie Embarking on Work Style Reform for Sales Reps, Lets Staffers Pick Locations
  October 28, 2019

• BUSINESS Chugai Notches Up Record Earnings in January-September on Hemlibra, Mainstays
  October 25, 2019

• REGULATORY Chuikyo Snubs Industry Request to Revisit Comparator Criteria in New Drug Pricing
  October 24, 2019

• BUSINESS Zolgensma’s Japan Launch Delayed into 2020 as Sakigake Review Drags On, MHLW Still Eager to Make Decision by Year-End
  October 23, 2019

• BUSINESS In Shocking U-Turn, Biogen/Eisai Say to File Aducanumab in Early Next Year
  October 23, 2019

• BUSINESS JAK Debuts Draw Near in Japan Atopic Dermatitis Market, 1st Likely to Get Listing Next Spring
  October 21, 2019

• ACADEMIA Nephrology Society Poised to Compile Drug Development Guidelines for Early-Stage Kidney Disease
  October 18, 2019

• BUSINESS FDA Gives Priority Status to Daiichi Sankyo/AZ’s HER2-Tageting ADC
  October 18, 2019

• BUSINESS Ranitidine Compensation Programs Draw Complaints from Pharmacists, Separate Billing Seen “Unrealistic”
  October 17, 2019

• BUSINESS Eyes Turn to SGLT2 Inhibitors after Entresto’s Narrow Miss in HFpEF
  October 16, 2019

• BUSINESS MSD Seeking to Trim 250 Jobs in Japan
  October 15, 2019

• BUSINESS GSK Japan to Pull Prescribed Zantac and Compensate for Substitutes; Generic Peers Follow
  October 11, 2019

• BUSINESS All Eyes on Performance of Top-2 Anti-Flu Drugs Xofluza, Inavir as Flu Seasons Approaches
  October 11, 2019

• REGULATORY Chuikyo Positive to Add Sakigake Drugs for PMP Coverage, Nudges Industry to Show Counterproposal for Company Criteria
  October 10, 2019

• BUSINESS AbbVie Japan Set to Join Oncology Fray with CLL Drug, Accelerating FIH Trial Entry
  October 9, 2019

• BUSINESS Wholesalers Working Out Systems to Comply with Promotion Guidelines, Show Mixed Approaches to External Oversight
  October 8, 2019

• REGULATORY As Curtain Rises on Diet, MHLW Aims to Get Amended PMD Bill Enacted in Early November
  October 7, 2019

• BUSINESS All 11 Manufacturers Pull Ranitidine from Shelves, “Class I” Recalls for 9 Firms
  October 4, 2019

• ORGANIZATION PhRMA Chair Urges Japan to Rectify PMP Criteria, Narrow Definition of Innovation
  October 4, 2019

• BUSINESS Novo Nordisk Poised to Cash in on New GLP-1 Agents to Hit 100 Billion Yen Japan Sales
  October 3, 2019

ページ

• « 先頭
• ‹ Prev
• …
• 119
• 120
• 121
• 122
• 123
• 124
• 125
• 126
• 127
• …
• Next ›
• 最終 »